News

Where to find the latest press

IACTA Pharmaceuticals' Licensed Technology Receives Royal Society of Chemistry Award

07.24.17 | PRESS RELEASE

IACTA Pharmaceuticals, Inc. today announces that the technology used in its dry eye candidate product NM133, Molecular Envelope Technology (MET), was recently awarded first prize in the Royal Society of Chemistry’s Emerging Technologies Competition...

Read more

IACTA Pharmaceuticals Licenses NM133 from Nanomerics for Treatment of Dry Eye

01.10.17 | PRESS RELEASE

IACTA Pharmaceuticals, Inc., a privately held pharmaceutical company, has acquired the North American rights to develop and commercialize NM133, an investigational medicine designed to help treat dry eye...

Read more

I am excited about our collaboration with Nanomerics, Ltd. MET technology provides an exciting platform for ocular drug delivery.

Damon Burrows

Founder / Chief Executive Officer

Partner with us

Working together will bring the iacta vision to life

Contact us